Hepion Pharmaceuticals, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -35.2% | -35.2% | -31.6% |
| FY2022 | -84.6% | -84.6% | -70.0% |
| FY2023 | -672.0% | -672.0% | -270.4% |
| FY2024 | 708.0% | 708.0% | -817.5% |
| FY2025 | -310.3% | -310.3% | -269.6% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -35.2% | -35.2% | -31.6% |
| FY2022 | -84.6% | -84.6% | -70.0% |
| FY2023 | -672.0% | -672.0% | -270.4% |
| FY2024 | 708.0% | 708.0% | -817.5% |
| FY2025 | -310.3% | -310.3% | -269.6% |